ChemicalBook > Product Catalog >Pharmaceutical intermediates >Bulk Drug Intermediates >(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
- CAS No.
- 179324-87-9
- Chemical Name:
- (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
- Synonyms
- (1R)-(S)-PINANEDIOL 1-AMMONIUM TRIFLUOROACETATE-3-METHYLBUTANE-1-BORONATE;(R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-triMethylhexahydro-4,6-Methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-aMine 2,2,2-trifluoroacetate;2,6<SUP>/SUP>(R)-BoroL;6-methano-1;Bortezomib INT A;eu-(+)-PinanedioL;7aR)-Hexahydro-3a
- CBNumber:
- CB21511721
- Molecular Formula:
- C17H29BF3NO4
- Molecular Weight:
- 379.23
- MOL File:
- 179324-87-9.mol
- Modify Date:
- 2024/4/3 15:02:28
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate Properties
Melting point | 157-159°C |
---|---|
storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
solubility | Ethanol (Slightly), Methanol (Slightly) |
form | Solid |
color | White to Off-White |
InChI | InChI=1/C15H28BNO2.C2HF3O2/c1-9(2)6-13(17)16-18-12-8-10-7-11(14(10,3)4)15(12,5)19-16;3-2(4,5)1(6)7/h9-13H,6-8,17H2,1-5H3;(H,6,7)/t10-,11-,12+,13-,15-;/s3 |
InChIKey | SRFQKJZNJYTMNI-XXOUUVOINA-N |
SMILES | C(F)(F)(F)C(=O)O.C[C@@]12OB([C@@H](N)CC(C)C)O[C@]1([H])C[C@]1([H])C[C@@]2([H])C1(C)C |&1:8,11,18,21,24,r| |
CAS DataBase Reference | 179324-87-9(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302-H315-H319-H332-H335 |
Precautionary statements | P261-P280-P305+P351+P338 |
Risk Statements | 36/37/38 |
Safety Statements | 26-36/37/39 |
HS Code | 29209090 |
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate price More Price(1)
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate Chemical Properties,Uses,Production
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 344)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
OPULENT PHARMA | +91-9106692785 +91-9106692785 | Gujarat, India | 479 | 58 | Inquiry |
Molkem Chemicals | +91-917228022464 +91-7228022464 | Ahmedabad, India | 138 | 58 | Inquiry |
RANI LIFE SCIENCES PVT LTD | +91-8008797507 +91-8008797507 | Hyderabad, India | 37 | 58 | Inquiry |
VGS SYNTHESIS PRIVATE LIMITED | +91-9866975588 +91-9866975588 | Hyderabad, India | 1817 | 58 | Inquiry |
RS LIFE SCIENCES | +91-9963585741 +91-9963585741 | Hyderabad, India | 32 | 58 | Inquiry |
Rivashaa Agrotech Biopharma Pvt. Ltd. | +91-26463395 +91-7926462688 | Gujarat, India | 1615 | 58 | Inquiry |
Myosynth Laboratories Pvt Ltd | +91-8913266227 +91-9885891884 | AndhraPradesh, India | 49 | 58 | Inquiry |
Vepan Pharmatech Pvt Ltd | +91-9908788828 +91-9966094448 | Telangana, India | 391 | 58 | Inquiry |
VIVAN Life Sciences Pvt. Limited. | +91(22) 2544 4584 / 2544 4585 | New Delhi, India | 138 | 50 | Inquiry |
Manus Aktteva | +91 (79) 6512-3395 | New Delhi, India | 581 | 34 | Inquiry |
179324-87-9((aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate)Related Search:
Cuminaldehyde
Cumene
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid
(S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID
((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid
chevron_left
1of4
chevron_right
(R)-BoroLeu-(+)-Pinanediol-CF3COOH
(R)-BoroLeu-(+)-Pinanediol-CF3CO2H
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate
Bortezomib Intermediate 1
(R)-BoroLeu-(+)-Pinanediol trifluoroacetate
(αR,3aS,4S,6S,7aR)-
(alphaR,3as,4s,6s,7ar)-Hexahydro-3a,8,8-triMethyl-alpha-(2-Methylpropyl)-4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine 2,2,2-trifluoroacetate
Pinanedioltrifluoroacetate salt-
BortezoMib I(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-triMethyl-alpha-(2-Methylpropyl)-4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine 2,2,2-trifluoroacetate
(R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-triMethylhexahydro-4,6-Methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-aMiniuM 2,2,2-trifluoroacetate
(αR)-(1S,2S,3R,5S)-Pinanediol-1-aMino-3-Methylbutane-1-boronate Trifluoroacetic Acid Salt
(R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate
Bortezomib Intermediates
Ixazomib intermediate
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methamine 2,2,2-trifluoroacetate
Bortezomib INT A
(R)-BoroLeu-(+)-Pinanediol-CF3COOH N-4
(1R)-(S)-pinanediol 1-aMMoniuM trifiuoroacetate-3-Methylbutane-1-boronate
(R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate 98%
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
(R)-3-Methyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methano-1,3,2-benzodioxaborol-2-yl]-1-butanamine 2,2,2-Trifluoroacetate
BoroLeu-(+)-Pinanediol
(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0<
/SUP>
]decan-4-yl]butan-1-amine
2,6<
SUP>
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-
(R)-BoroL
eu-(+)-PinanedioL
(1S,2S,3R,5S)-Pinane-2,3-diol leucineboronate trifluoroacetate salt
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxabor
Bortezomib Intermediate A
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αR,3aS,4S,6S,7aR)-, 2,2,2-trifluoroacetate (1:1)
Ixazomib Impurity 28
2-benzodioxaborole-2-methanamine 2
6-methano-1
7aR)-Hexahydro-3a
8-trimethyl-alpha-(2-methylpropyl)-4
(R)-BoroLeu-(+)-Pinanediol trifluoroacetate (Bortezomib Impurity)
Bortezomib Amino R Isomer
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methy...
(1R)-(S)-Pinanediol 1-ammonium trifluoroacetate-3-methylbutane-1-boronate (TFA)
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate
(1R)-(S)-pinanediol-1-Ammonium Trifluoroacetate-3-methlbutane-1-boronate
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt
(1R)-(S)-PINANEDIOL 1-AMMONIUM TRIFLUOROACETATE-3-METHYLBUTANE-1-BORONATE
(R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-triMethylhexahydro-4,6-Methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-aMine 2,2,2-trifluoroacetate
(R) Pinanediol 1-amino-3-methylbutyl borate trifluoroacetate
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αR,3aS,4S,6S,7aR)-,2,2,2-trifluoroacetate (1:1)
(aR,3aS,4S,6S,7aR)- hexahydro -3a,8,8- trimethyl -alpha-(2- methylpropyl) -4,6- methyl bridge -1,3,2- benzodioxolane -2- methylamine 2,2,2- trifluoroacetate
(αR,3aS,4S,6S,7aR)-hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-Methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate (1:1)
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-a-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine TFA
(R)-Boroleucine (1S 2S 3R 5S)-(+)-2 3-pinanediol ester trifluoroacetate.
(R)-1-Amino-3-methylbutylboronic acid pinanediol ester trifluoroacetate
(R)-BoroLeu-(+)-Pinanedioltrifluoroacetate salt
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodiox